Viewing Study NCT04007003


Ignite Creation Date: 2025-12-24 @ 7:42 PM
Ignite Modification Date: 2026-01-01 @ 8:26 AM
Study NCT ID: NCT04007003
Status: TERMINATED
Last Update Posted: 2019-12-03
First Post: 2019-06-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Audit of the Impact of Tailored Information Delivered Via a Digital Learning Platform
Sponsor: Becton, Dickinson and Company
Organization:

Study Overview

Official Title: An Audit of the Impact of Tailored Information Delivered Via a Digital Learning Platform
Status: TERMINATED
Status Verified Date: 2019-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Sponsor decision
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The study intends to audit the impact of optimal insulin injection technique on clinical parameters and self-care behaviour of insulin treated diabetes patients in a prospective manner with a follow-up of 6 months. The optimal injection technique is delivered through education via a multimodal tailored approach augmented with a digital 'tailorable' patient learning platform .

The study is conducted in multiple sites across Belgium. Diabetes patients with or without lipohypertrophy will be entered into the audit. The end points will include the impact on use of insulin, long term blood glucose control (HbA1c), hypoglycaemia, glucose variability, needle reuse, patient injection habits and clinician education, training and information inputs.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: